Are mesenchymal stem cells a promising treatment for Covid-19?

Clinical trials for Covid-19 treatment

A recent pilot study in China, in which seven Covid-19 patients received intravenous infusions of mesenchymal stem cells, indicates that the intervention was safe and that the approach may improve patient outcomes.

Partagez sur vos réseaux sociaux

Write a comment

Comments: 0